Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M44,671Revenue (TTM) $M4,435Net Margin (%)16.4Altman Z-Score13.9
Enterprise Value $M44,184EPS (TTM) $6.3Operating Margin %29.3Piotroski F-Score7
P/E(ttm)67.5Beneish M-Score-2.4Pre-tax Margin (%)28.8Higher ROA y-yY
Price/Book11.910-y EBITDA Growth Rate %--Quick Ratio3.1Cash flow > EarningsY
Price/Sales11.05-y EBITDA Growth Rate %--Current Ratio3.4Lower Leverage y-yY
Price/Free Cash Flow62.1y-y EBITDA Growth Rate %43.6ROA % (ttm)14.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)21.3Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M105ROIC % (ttm)24.8Gross Margin Increase y-yN

Gurus Latest Trades with REGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
REGNVanguard Health Care Fund 2016-03-31 Add0.71%$359.68 - $542.87
($414.39)
$ 425.123%Add 38.98%3,169,490
REGNRon Baron 2016-03-31 Reduce-0.01%$359.68 - $542.87
($414.39)
$ 425.123%Reduce -32.86%5,011
REGNJoel Greenblatt 2016-03-31 Reduce-0.01%$359.68 - $542.87
($414.39)
$ 425.123%Reduce -39.26%2,525
REGNMario Gabelli 2016-03-31 Reduce$359.68 - $542.87
($414.39)
$ 425.123%Reduce -2.54%1,343
REGNKen Fisher 2016-03-31 Reduce$359.68 - $542.87
($414.39)
$ 425.123%Reduce -0.33%613
REGNVanguard Health Care Fund 2015-12-31 Reduce-0.17%$459.82 - $587.09
($543.11)
$ 425.12-22%Reduce -6.84%2,280,494
REGNJoel Greenblatt 2015-12-31 Buy 0.02%$459.82 - $587.09
($543.11)
$ 425.12-22%New holding4,157
REGNMario Gabelli 2015-12-31 Reduce$459.82 - $587.09
($543.11)
$ 425.12-22%Reduce -35.76%1,378
REGNKen Fisher 2015-12-31 Add$459.82 - $587.09
($542.9)
$ 425.12-22%Add 22.02%615
REGNVanguard Health Care Fund 2015-09-30 Reduce-0.32%$451.82 - $592.4
($537.03)
$ 425.12-21%Reduce -11.45%2,447,894
REGNRon Baron 2015-09-30 Reduce$451.82 - $592.4
($537.03)
$ 425.12-21%Reduce -0.21%7,463
REGNKen Fisher 2015-09-30 Reduce$451.82 - $592.4
($537.03)
$ 425.12-21%Reduce -10.80%504
REGNVanguard Health Care Fund 2015-06-30 Reduce-0.15%$438.27 - $539.4
($487.44)
$ 425.12-13%Reduce -5.36%2,764,540
REGNKen Fisher 2015-06-30 Add$438.27 - $539.4
($487.44)
$ 425.12-13%Add 5.81%565
REGNMario Gabelli 2015-06-30 Reduce$438.27 - $539.4
($487.44)
$ 425.12-13%Reduce -2.05%2,145
REGNRon Baron 2015-06-30 Reduce$438.27 - $539.4
($487.44)
$ 425.12-13%Reduce -0.15%7,479
REGNKen Fisher 2015-03-31 Add$396.89 - $488.87
($423.8)
$ 425.120%Add 1.91%534
REGNVanguard Health Care Fund 2014-12-31 Add0.12%$328.07 - $434.95
($393.59)
$ 425.128%Add 4.49%2,921,000
REGNJoel Greenblatt 2014-12-31 Sold Out -0.01%$328.07 - $434.95
($394.04)
$ 425.128%Sold Out0
REGNJoel Greenblatt 2014-09-30 Add$296.41 - $364.41
($335.27)
$ 425.1227%Add 60.05%1,410
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

REGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


REGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2016-06-14Buy64,731$363.8612.97view
RYAN ARTHUR FDirector 2016-05-24Sell1,000$396.643.63view
Van Plew Daniel PEVP & General Mgr Industrial O 2016-05-18Sell4,413$385.776.55view
GOLDSTEIN JOSEPH LDirector 2016-04-06Sell2,000$425-3.28view
GOLDSTEIN JOSEPH LDirector 2016-03-21Sell2,000$3759.61view
Sanofi10% Owner 2016-02-17Buy161,157$392.464.73view
Sanofi10% Owner 2016-01-12Buy83,938$465.04-11.61view
McCorkle Douglas SVP Controller and Asst Treasur 2015-12-29Sell3,954$552.08-25.55view
BROWN MICHAEL SDirector 2015-12-10Sell3,000$546.45-24.78view
YANCOPOULOS GEORGEPresident Regeneron Laboratori 2015-12-02Sell43,348$549.03-25.13view

Quarterly/Annual Reports about REGN:

News about REGN:

Articles On GuruFocus.com
Frank Sands Sells Visa, Baidu, Alibaba May 24 2016 
Baron Funds Comments on Regeneron Pharmaceuticals May 23 2016 
Market-Beating Vanguard Health Care Fund Adds Shares to 5 Positions May 03 2016 
Vanguard Boosts Stake in Incyte in 1st Quarter May 02 2016 
Amgen: Should I Just Sit and Wait? Mar 18 2016 
Weekly CFO Sells Highlights: Facebook, Fitbit, Regeneron Pharmaceuticals Nov 23 2015 
The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings Nov 04 2015 
Weekly CFO Sells Highlight: Acadia Healthcare, Facebook, Regeneron Pharmaceuticals Aug 24 2015 
Weekly Insider Sells Highlights: FB, AET, REGN, TYC Aug 18 2015 
Brean Capital Weighs in on Medivation Following Update on TERRAIN Study Mar 26 2015 

More From Other Websites
What Do Analysts Recommend for Shire? Jul 26 2016
Understanding Improvement in Vertex Pharmaceuticals’s PE Multiple Jul 25 2016
Eli Lilly, J&J, Novo Battle Diabetes -- And Each Other Jul 22 2016
What Do Analysts Recommend for United Therapeutics? Jul 22 2016
Analysts Gauge Alexion Pharmaceuticals’ Return Potential Jul 21 2016
Regeneron Pharmaceuticals, Inc. – Value Analysis (NASDAQ:REGN) : July 18, 2016 Jul 18 2016
Regeneron Announces Upcoming 2016 Investor Conference Presentation Jul 18 2016
Biotech: 'We Would Not Be Surprised to See Volatility Continue' Jul 13 2016
Regeneron’s Dupilumab: How Much Potential Does It Hold? Jul 13 2016
Regeneron Announces 2016 Winners of the Regeneron Prize for Creative Innovation Jul 13 2016
Regeneron’s Robust Pipeline Jul 12 2016
5 Stocks Set to Soar on Bullish Earnings Jul 12 2016
What’s Driving Regeneron’s Premium Valuation? Jul 12 2016
Award-Winning Chef Elizabeth Falkner Reveals Her Struggle with Atopic Dermatitis to Highlight the... Jul 12 2016
What’s behind Regeneron’s Operating Efficiency? Jul 11 2016
Is It Slower Growth for Regeneron’s Eylea in 2016 and 2017? Jul 11 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)